After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml ...
HYDERABAD, India & REYKJAVIK, Iceland I March 18, 2025 I Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with ...
375 for a 5 mg vial, leading to a monthly cost of Rs14,000-Rs17,500, depending on dosage. In the U.S., Mounjaro carries a ...
Stock Market Highlights: Sensex rallies for 6th day, adds 1,078pts, Nifty at 23,658; PSB outperforms
Banking shares stole the show among the sectoral indices, with PSU banks leading the charge, as the Nifty PSU Bank index ...
11d
Zacks.com on MSNFDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for ReviewDr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.
Dr. Reddy’s Laboratories (NYSE:RDY) and Alvotech (NASDAQ:ALVO) announced that the U.S. FDA has accepted a Biologic License ...
Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide ... in a range of doses from 2.5 mg to 15 mg per 0.5 mL in a single-dose pen (autoinjector), with recommended ...
6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark Pharmaceuticals Limited were trading at ₹1,286.30, up by ₹7.35 or 0.57 per cent on the NSE today at 10.13 am.
Sensex, Nifty updates on 24 March 2025. The benchmark BSE Sensex jumped 1.4% to 77,984.38, while the NSE Nifty gained 1.32% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results